Wright Lassiter III - Jul 1, 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
Director
Signature
Sean D. Mersten, Attorney in Fact for Wright L. Lassiter, III
Stock symbol
DGX
Transactions as of
Jul 1, 2025
Transactions value $
$0
Form type
4
Date filed
7/2/2025, 04:26 PM
Previous filing
Jun 4, 2025
Next filing
Jul 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lassiter Wright III Director 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS, SECAUCUS Sean D. Mersten, Attorney in Fact for Wright L. Lassiter, III 2025-07-02 0001805909

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Phantom Stock Units Award $0 +160 +44.34% $0.00 521 Jul 1, 2025 Common Stock 160 $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
F2 Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.